The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells-Reference-Cited by-同舟云学术

The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells

Published:2006-06 Issue:6 Volume:34 Page:753-759
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Fischer Lars,Penack Olaf,Gentilini Chiara,Nogai Axel,Muessig Arne,Thiel Eckhard,Uharek Lutz

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference50 articles.

1. Therapeutic monoclonal antibodies in oncology;Levene;J R Soc Med,2005

2. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998

3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

4. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation;Colombat;Blood,2001

5. Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma;Hainsworth;J Clin Oncol,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blue mussel (Mytilus edulis) water extract ameliorates intestinal immune response in high-fat diet–streptozotocin-induced diabetic mice;Food & Function;2024

2. Development and implementation of natural killer cell simultaneous ADCC and direct killing assay;Heliyon;2023-12

3. Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential;Cancers;2022-11-24

4. TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy;Molecular Pharmaceutics;2020-05-08

5. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial;Journal of Cancer Research and Clinical Oncology;2019-07-04